Workflow
嘉和美康: 华泰联合证券有限责任公司关于嘉和美康(北京)科技股份有限公司首次公开发行股票并在科创板上市之保荐总结报告书

Group 1 - The core viewpoint of the report is to summarize the sponsorship activities and compliance of Huatai United Securities in relation to the initial public offering (IPO) of Jiahe Meikang (Beijing) Technology Co., Ltd. on the Sci-Tech Innovation Board [1][3][10] - The issuer, Jiahe Meikang, has a registered capital of 137,585,598 yuan and was listed on December 14, 2021, with the stock code 688246.SH [1][3] - The total net proceeds from the IPO amounted to 1,240,457,179.15 yuan, which were allocated to various projects including electronic medical record development and operational funds [4][10] Group 2 - During the continuous supervision period, the sponsor conducted semi-annual inspections of the use and storage of raised funds, ensuring compliance with regulations [3][4] - The sponsor issued a total of 18 verification opinions regarding the issuer's use of raised funds and did not issue any dissenting opinions [4][10] - The issuer's shareholders, specifically the Xianning Kaixuan Opportunity Growth Fund, failed to timely fulfill commitments related to share reduction, leading to regulatory actions [5][7] Group 3 - The issuer discovered accounting errors in the financial statements for 2022 and 2023, which were corrected through retrospective adjustments approved by the board [10][11] - The sponsor confirmed that the issuer complied with relevant regulations in the use of raised funds and maintained proper disclosure practices [10][12] - As of December 31, 2024, the raised funds had not been fully utilized, and the sponsor will continue to oversee the usage until completion [12]